Category: Health
The FDA has approved the Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older, marking the first blood test approved as a primary screening option. This test aims to increase screening rates and early detection, potentially saving lives. It has shown an accuracy rate comparable to existing stool tests and is expected to be commercially available soon.
Keywords: colorectal cancer, FDA approval, blood test
Update At: 7/30/2024